CAR therapies

Verismo Therapeutics Files IND to Study Cell Therapy in Advanced Mesothelin-Expressing Solid Tumors

Innovative Cellular Therapies Begins Trial of Autologous CAR T-Cell Therapy in Colorectal Cancer

Tessa Therapeutics Starts Trial of CAR T-Cell Therapy, BMS's Opdivo in Classical Hodgkin Lymphoma

Anixa Biosciences Doses First Ovarian Cancer Patient in Novel Autologous Cell Therapy Trial

Bristol Myers Squibb, 2seventy Bio Eyeing Earlier-Line Multiple Myeloma Abecma Indication

OriCell Therapeutics Raises $120M in Series B Round

Legend Biotech Aims to Raise $250M via Public Offering of American Depositary Shares

Gilead's Tecartus Gets EMA CHMP Recommendation in Advanced ALL

Legend Biotech Shutters Trial of CD4-Directed CAR T-Cell Therapy for T-Cell Lymphoma

European Commission Approves Gilead Sciences' Yescarta for Follicular Lymphoma Patients

FDA Approves Bristol Myers Squibb's Breyanzi for Second-Line Lymphoma Patients

BMS Submits Breyanzi for European Approval as Second-Line Lymphoma Treatment

Mnemo Therapeutics Kicks Off CAR T Clinical Collaboration With €10M Grant

Eureka, City of Hope Begin Phase I/II Trial of T-Cell Therapy in GPC3-Positive Liver Cancer

Novartis' Kymriah Nabs FDA Approval in Refractory Follicular Lymphoma

BMS Shows Breyanzi Benefit in Stem Cell Transplant-Ineligible LBCL

European Commission Gives Conditional Approval to Carvykti for Multiple Myeloma